Leniolisib Shows Activity Across Genetically Defined Immune Dysregulation

Company Pharming Event Type Clinical Data Readout Modality Small Molecule Asset Leniolisib Target PI3K delta Disease Area Genetically Defined Primary Immunodeficiencies Summary Pharming reported positive topline data from 13 participants with genetically defined primary immunodeficiencies linked to PI3K signaling. In the open label within patient…